The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: A randomized double-blind placebo-controlled trial

Diabetes, Obesity and Metabolism

Volumn 15, Issue 5, 2013, Pages 448-454

  Tong, X L ^a   Wu, S T ^b   Lian, F M ^a   Zhao, M ^c   Zhou, S P ^c   Chen, X Y ^a   Yu, B ^a   Zhen, Z ^a   Qi, L W ^d   Li, P ^d   Wang, C Z ^e   Sun, H ^c,f   Yuan, C S ^e  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Tianjin Tasly Group Co Ltd   (China)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

^e UNIVERSITY OF CHICAGO   (United States)

^f TIANJIN UNIVERSITY   (China)

Author keywords

Chinese medicine; FPG; HbA1c; HOMA IR; HOMA ; Rhizoma Coptidis; Tang Min Ling Wan or TM81; Type 2 diabetes

Indexed keywords

CHINESE DRUG; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TANG MIN LING WAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADIPOSE TISSUE; ADULT; ARTICLE; BITTER TASTE; BODY MASS; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRY THROAT; ELECTROCARDIOGRAM; EXCITABILITY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRRITABILITY; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; OVERWEIGHT; TREATMENT OUTCOME;

EID: 84876342689     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12051     Document Type: Article

References (23)

1. Danaei G, Finucane MM, Lu Y et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40.
2. Yang SH, Dou KF, Song WJ. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 2425-2426.
3. Yang LX, Liu TH, Huang ZT, Li JE, Wu LL. Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus. Chin J Integr Med 2011; 17: 235-240.
4. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010; 153: 147-157.
5. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008; 57: 712-717.
6. Zhao HL, Sui Y, Qiao CF, Yip KY, Leung RK et al. Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression. Diabetes 2012; 61: 933-943.
7. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 2010; 19: 1297-1307.
8. Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011; 13: 289-301.
9. Li B, Zhu WL, Chen KX. Advances in the study of berberine and its derivatives. Yao Xue Xue Bao 2008; 43: 773-787.
10. Zhou JY, Zhou SW. Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 2011; 82: 184-189.
11. Akiyama S, Katsumata S, Suzuki K, Nakaya Y, Ishimi Y et al. Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci Biotechnol Biochem 2009; 73: 2779-2782.
12. Mohan Maruga Raja MK, Mishra SH. Comprehensive review of Clerodendrum phlomidis: a traditionally used bitter. Zhong Xi Yi Jie He Xue Bao 2010; 8: 510-524.
13. Li HT, Wu XD, Davey AK, Wang J. Antihyperglycemic effects of baicalin on streptozotocin - nicotinamide induced diabetic rats. Phytother Res 2011; 25: 189-194.
14. Yang HZ, Zhou MM, Zhao AH, Xing SN, Fan ZQ et al. Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro. Zhong Yao Cai 2009; 32: 1259-1261.
15. Waisundara VY, Hsu A, Tan BK, Huang D. Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes Metab Res Rev 2009; 25: 671-677.
16. Zhen Z, Chang B, Li M et al. Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. Am J Chin Med 2011; 39: 53-63.
17. Tong XL, Ni Q, Lian FM, Hu JQ, Yu FH et al. Multi-center randomized controlled and doub1e blind trai1 of Tang-Min-ling pills in the treatment of type 2 diabetes mellitus. Chin J Clin Phamacol 2009; 25: 104-108.
18. WHO. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
19. Hanefeld M, Herman GA, Wu M, Mickel C, Sanchez M et al. Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes. Curr Med Res Opin 2007; 23: 1329-1339.
20. Patel A, MacMahon S, Chalmers J, Neal B, Billot L et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
21. Sosnowski C, Janeczko-Sosnowska E. The action to control cardiovascular risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. Kardiol Pol 2008; 66: 1013-1019.
22. Anderson RJ, Bahn GD, Moritz TE, Kaufman D, Abraira C et al. Blood pressure and cardiovascular disease risk in the veterans affairs diabetes trial. Diabetes Care 2011; 34: 34-38.
23. Bennett WL, Wilson LM, Bolen S, Maruthur N, Singh S et al. Oral Diabetes Medications for Adults with Type 2 Diabetes: An Update. Baltimore: Agency for Healthcare Research and Quality, 2011.